Stocks · Healthcare · Medical - Devices
Alphatec Holdings, Inc. ATEC
$10.03 +1.31% Close, Oct 2, 2026 · NASDAQ · Market cap $1.54B
Weak trend
Next earnings report: Oct 29, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -5.6% from -16.8% a year earlier.
- Net debt is 36.1× EBITDA, a high level of leverage.
- The stock is 56% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth68Positive
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 34%
- Revenue growth, 3-year CAGRTop 22%
- Revenue growth accelerationBottom 31%
Quality60Neutral
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 40%
- Gross marginTop 48%
- Operating marginTop 48%
- Accruals (lower is better)Top 12%
- Net debt / EBITDA (lower is better)Bottom 2%
- Interest coverTop 48%
Value70Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 48%
- Free-cash-flow yieldTop 35%
- EBITDA / enterprise valueTop 36%
- Sales / enterprise valueTop 32%
Momentum19Very weak
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 13%
- 6-month returnBottom 35%
- 1-year return vs S&P 500Bottom 24%
- Distance from 52-week highBottom 20%
- Trend checklist (0–4)Bottom 38%
Revisions29Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 35%
- Upside to consensus price targetTop 50%
Stability40Weak
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 40%
- Maximum drawdown, 3 yearsBottom 50%
- Beta vs S&P 500 (lower is better)Top 18%
- Net debt / EBITDA (lower is better)Bottom 2%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 22.5% | 19.5% | ↓ |
| Gross margin | 68.8% | 66.1% | ↓ |
| Operating margin | -16.8% | -5.6% | ↑ |
| FCF margin | -4.4% | 0.5% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 19.5% | 22.5% | ↓ | Top 34% |
| Gross margin | 66.1% | 68.8% | ↓ | Top 48% |
| Operating margin | -5.6% | -16.8% | ↑ | Top 48% |
| Net margin | -13.5% | -24.3% | ↑ | — |
| Free-cash-flow margin | 0.5% | -4.4% | ↑ | — |
| Return on invested capital | -7.2% | — | Top 40% | |
| Revenue growth, 3-year CAGR | 29.6% | — | Top 22% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -21.1%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 9.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -9.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 36.07×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -1.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.08%
- Shareholder yield
- -0.08%
- Share count change, 1 year
- +3.6%
- Share count change, 3-year CAGR
- +9.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +1.7%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $16.22
- Target vs current price
- +61.7%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 85%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +0.8% | +2.0% | -6.5% | -7.7% | — |
| May 5, 2026 | -2100.0% | -1.0% | -32.3% | -27.6% | -6.5% |
| Feb 24, 2026 | +50.0% | +5.9% | +2.4% | -7.7% | -37.5% |
| Oct 30, 2025 | +200.0% | -1.0% | +19.6% | +37.0% | -7.5% |
| Jul 31, 2025 | +133.3% | -1.4% | +41.7% | +50.8% | +48.1% |
| May 1, 2025 | -91.7% | +0.7% | +13.4% | +13.5% | +1.9% |
| Feb 26, 2025 | -21.1% | +4.7% | +11.1% | -2.3% | +19.9% |
| Oct 30, 2024 | -12.0% | +3.7% | +58.3% | +77.3% | +111.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.07 | $0.07 | +0.8% | $213.5M |
| May 5, 2026 | -$0.22 | -$0.01 | -2100.0% | $192.1M |
| Feb 24, 2026 | $0.06 | $0.04 | +50.0% | $212.9M |
| Oct 30, 2025 | $0.03 | -$0.03 | +200.0% | $196.5M |
| Jul 31, 2025 | $0.02 | -$0.06 | +133.3% | $185.5M |
| May 1, 2025 | -$0.23 | -$0.12 | -91.7% | $169.2M |
| Feb 26, 2025 | -$0.23 | -$0.19 | -21.1% | $177.0M |
| Oct 30, 2024 | -$0.28 | -$0.25 | -12.0% | $150.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 30.7× | — | — | — |
| EV / EBITDA | 150.7× | — | — | Top 36% |
| EV / Sales | 2.49× | — | — | Top 32% |
| Free-cash-flow yield | 0.27% | — | — | Top 35% |
| Earnings yield | -7.18% | — | — | Top 48% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 16
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +4.6%
- 200-day average slope (20 days)
- -8.5%
- Distance from 50-day average
- +3.6%
- Distance from 200-day average
- -13.0%
- RSI (14)
- 51.8
- Relative volume
- 0.90×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 60.7%
- Volatility vs own 5-year history
- 54th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.56
- Correlation with S&P 500
- 0.12
- Current drawdown from 1-year high
- -55.8%
- Maximum drawdown, 3 years
- -70.3%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jul 13, 2023 | Oct 10, 2024 | -73.5% | 314 days | 265 days (Oct 31, 2025) |
| Jan 8, 2026 | May 6, 2026 | -69.2% | 81 days | Not yet recovered |
| Mar 22, 2021 | Jun 21, 2022 | -66.1% | 315 days | 266 days (Jul 13, 2023) |
| Oct 15, 2020 | Oct 28, 2020 | -17.7% | 9 days | 15 days (Nov 18, 2020) |
| Nov 26, 2025 | Dec 17, 2025 | -13.4% | 14 days | 14 days (Jan 8, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.54B
- EPS, diluted (TTM)
- -$0.72
- Revenue (TTM)
- $815.1M
- 52-week range
- $6.82 – $23.29
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $243.2M | $350.9M | $482.3M | $611.6M | $764.2M |
| Gross profit | $157.8M | $233.1M | $310.2M | $424.3M | $531.9M |
| Operating income | -$128.1M | -$147.0M | -$173.4M | -$136.2M | -$82.1M |
| Net income | -$143.0M | -$151.3M | -$186.6M | -$162.1M | -$143.4M |
| EPS (diluted) | -$1.50 | -$1.47 | -$1.54 | -$1.13 | -$0.96 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $150.7M | $176.8M | $169.2M | $185.5M | $196.5M | $212.9M | $192.1M | $213.5M |
| Net income | -$39.6M | -$33.3M | -$51.9M | -$41.1M | -$28.6M | -$21.7M | -$33.9M | -$25.8M |
| EPS (diluted) | -$0.28 | -$0.23 | -$0.35 | -$0.27 | -$0.19 | -$0.15 | -$0.22 | -$0.16 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$73.3M | -$75.1M | -$78.5M | -$44.7M | $45.2M |
| Capital expenditure | -$68.5M | -$58.3M | -$87.0M | -$93.1M | -$42.5M |
| Free cash flow | -$141.9M | -$133.4M | -$165.5M | -$137.8M | $2.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $100.9M | -$3.0M | $212.1M | -$560,000 | $515,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $118.7M
- Total assets
- $791.0M
- Total liabilities
- $803.1M
- Total debt
- $604.0M
- Net debt
- $485.4M
- Shareholders’ equity
- -$12.1M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 14,429,283
- Days to cover
- 5.50
- Change vs previous report
- +5.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Aug 25, 2016
- 1-for-12